In-depth study of antiviral RNA silencing in Caenorhabditis elegans

秀丽隐杆线虫抗病毒RNA沉默的深入研究

基本信息

  • 批准号:
    9403202
  • 负责人:
  • 金额:
    $ 28.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-01-01 至 2021-12-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Antiviral RNA silencing (AvRS), also referred to as antiviral RNA interference (RNAi), acts as a major antiviral innate mechanism in fungi, plants, and invertebrates. Recent observations suggest that AvRS is also active in undifferentiated mouse cells and appears to be essential for developing mouse babies to fight against lethal viral pathogen. Virus destruction in AvRS is guided by small interfering RNAs derived from viral double-stranded RNAs (dsRNAs), usually the replication intermediates. Therefore, genetic mutations that accumulate in the viral genome during the term of virus replication do not confer resistance to AvRS. Hence, mechanistic study of AvRS holds promise for developing novel strategies for the treatment of viral infection caused human diseases. In mammals, interferon mediated antiviral immunity represents a major innate immunity against viral infection. This antiviral immunity is often triggered upon the detection of invading viral RNAs by three closely related RNA helicases termed RIG-I-like RNA helicases (RLHs). Among these three RLHs, RIG-I and MDA5 detect virus-produced double-stranded RNAs (dsRNAs) in a sequence- independent manner and, thus, are also resistant to genetic changes within the viral genome. Thus, findings from the study of RLH mediated virus detection is also expected to facilitate the development of novel antiviral therapies. Increasing evidence suggests that RIG-I also plays essential role in regulating mammal development. Currently, it remains to be an open question how RIG-I regulates development in mammals Viruses naturally infect and trigger AvRS in Caenorhabditis elegans, making C. elegans an ideal model organism for the study of AvRS. Compared to other model organism, C. elegans has so far the most, in terms of type species, genes identified as key components of AvRS. Because of its short life span and genetic tractability, C. elegans also allows for rapid identification of novel AvRS genes for in-depth study of AvRS. More importantly, accumulating evidence suggests that worm RLHs contribute to both AvRS, by acting as a virus sensor, and worm development. Thus, C. elegans as a model system would serve us well in addressing the question how the virus detection function of RLHs is regulated and how RLHs contribute to the regulation of development. This application seeks to work on (1) genetic and functional characterization of the candidate AvRS genes isolated from a random genetic screen; (2) mechanistic study of worm AvRS initiation; (3) mechanistic study of viral transcript destruction by worm AvRS. Findings from the proposed research are expected to not only improve our understanding of worm AvRS but also facilitate our study on the regulation of RLH function in virus detection and the regulation of development by RIG-I in mammals.
项目摘要 抗病毒RNA沉默(AvRS),也称为抗病毒RNA干扰(RNAi), 真菌、植物和无脊椎动物中的主要抗病毒先天机制。最近的观察表明, AvRS在未分化的小鼠细胞中也有活性,似乎对发育中的小鼠至关重要。 婴儿对抗致命的病毒病原体。AvRS中的病毒破坏由小干扰 来源于病毒双链RNA(dsRNA)的RNA,通常是复制的中间产物。 因此,在病毒复制期间在病毒基因组中积累的基因突变 不会对AvRS产生耐药性。因此,对AvRS机理的研究有望为开发 用于治疗病毒感染引起的人类疾病的新策略。 在哺乳动物中,干扰素介导的抗病毒免疫代表了主要的先天免疫, 病毒感染这种抗病毒免疫通常在检测到入侵的病毒RNA时被触发, 三种密切相关的RNA解旋酶称为RIG-I样RNA解旋酶(RLH)。这三 RLH、RIG-I和MDA 5检测病毒产生的双链RNA(dsRNA), 独立的方式,因此也对病毒基因组内的遗传变化具有抵抗力。因此,在本发明中, RLH介导的病毒检测研究的结果也有望促进 新的抗病毒疗法。越来越多的证据表明,RIG-I也发挥着重要作用, 调节哺乳动物的发育。目前,RIG-I如何调节仍然是一个悬而未决的问题, 哺乳动物发育 病毒自然感染并触发秀丽隐杆线虫中的AvRS,使C.一个理想的优雅 研究AvRS的模式生物。与其他模式生物相比,C.到目前为止, 大多数,在模式物种方面,基因被确定为AvRS的关键组成部分。因为它的寿命很短 跨度和遗传易处理性,C.线虫还允许快速鉴定新的AvRS基因, 深入研究AvRS。更重要的是,越来越多的证据表明, 通过充当病毒传感器,对AvRS和蠕虫的发展都有贡献。因此,C.优雅作为一个 模型系统将很好地解决RLH病毒检测功能的问题 以及RLH如何对发育的调节做出贡献。 本申请旨在研究(1)候选人的遗传和功能特征 (2)蠕虫AvRS启动机制的研究; (3)蠕虫AvRS破坏病毒转录物的机制研究。建议的调查结果 研究预计不仅可以提高我们对蠕虫AvRS的理解, RLH在病毒检测中的功能调控及RIG-I对发育的调控研究 在哺乳动物中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rui Lu其他文献

Rui Lu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rui Lu', 18)}}的其他基金

Negative regulation of human antiviral RNAi by PACT
PACT 对人类抗病毒 RNAi 的负调控
  • 批准号:
    10667112
  • 财政年份:
    2023
  • 资助金额:
    $ 28.53万
  • 项目类别:
MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia
MEF2D 介导的急性髓系白血病转录控制
  • 批准号:
    10542726
  • 财政年份:
    2021
  • 资助金额:
    $ 28.53万
  • 项目类别:
MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia
MEF2D 介导的急性髓系白血病转录控制
  • 批准号:
    10365298
  • 财政年份:
    2021
  • 资助金额:
    $ 28.53万
  • 项目类别:
In-depth study of antiviral RNA silencing in Caenorhabditis elegans
秀丽隐杆线虫抗病毒RNA沉默的深入研究
  • 批准号:
    9239852
  • 财政年份:
    2017
  • 资助金额:
    $ 28.53万
  • 项目类别:
Cytosolic virus detection in Caenorhabditis elegans
秀丽隐杆线虫胞浆病毒检测
  • 批准号:
    8824358
  • 财政年份:
    2014
  • 资助金额:
    $ 28.53万
  • 项目类别:
The functional role of DRH-1 in RNAi directed viral immunity
DRH-1 在 RNAi 定向病毒免疫中的功能作用
  • 批准号:
    8242983
  • 财政年份:
    2012
  • 资助金额:
    $ 28.53万
  • 项目类别:
The functional role of DRH-1 in RNAi directed viral immunity
DRH-1 在 RNAi 定向病毒免疫中的功能作用
  • 批准号:
    8415513
  • 财政年份:
    2012
  • 资助金额:
    $ 28.53万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 28.53万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 28.53万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 28.53万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 28.53万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 28.53万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 28.53万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 28.53万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 28.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 28.53万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 28.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了